Cooperative-Agreement
Cooperative-Agreement funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
RFA-CA-27-016: The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required)
NIH/NCI’s ETCTN NOFO seeks institutions that can lead early-phase cancer therapeutic trials within the NCI Cancer Therapy Evaluation Program, using the UM1 cooperative agreement model with a strong focus on trial activation, accrual, and mentorship for early career investigators.
RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
NCI’s RFA-CA-27-021 supports advanced and widely adopted cancer informatics resources through U24 sustained-support awards, with $1.8 million committed in FY 2027 across two awards.
RFA-DE-27-002: Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed)
NIH Notice of Funding Opportunity to build a U24 Tissue Engineering and Regenerative Medicine Resource Center with an initial cohort of Interdisciplinary Translational Projects focused on pre-clinical de-risking and FDA-oriented readiness.
RFA-FD-25-007: Laboratory Flexible Funding Model (LFFM)
FDA's Laboratory Flexible Funding Model Cooperative Agreement supports state and public laboratories to expand food safety and food defense testing capacity through structured analytical tracks in microbiology, chemistry, and radiochemistry.
RFA-JG-26-034: Enhancing Understanding and Preparedness for Public Health Threats Through Research in Kenya
A CDC cooperative agreement to support Kenya-focused research, implementation science, and public-health evaluations across four priority areas to strengthen disease detection, prevention, and response systems.
RFA-MH-26-120: BRAIN Initiative Reagent Resources for Brain Cell Type-Specific Access (U24)
NIH’s BRAIN Initiative cooperative agreement funds facilities that produce and distribute brain cell type-specific access and manipulation reagents for neuroscience users.
RFA-MH-27-205: Single Source: Accelerating Medicines Partnership Schizophrenia DPACC
NIH is inviting a single-source U24 cooperative agreement to Brigham and Women's Hospital for continuation of the AMP Schizophrenia Data Processing, Analysis, and Coordination Center, with applications due 9 June 2026 and one full award anticipated in FY2027.
RFA-NS-25-017: BRAIN Initiative—Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System
The NIH BRAIN Initiative FOA supports U01 projects that optimize existing neural recording and modulation technologies for use in behaving animals, with recurring application cycles through 2026 and 2027.
RFA-NS-25-021: BRAIN Initiative Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)
NIH BRAIN Initiative cooperative agreement to accelerate translational development of recording and modulation devices for CNS disorders through milestone-driven UG3/UH3 funding and small clinical studies requiring FDA IDE pathways.
RFA-NS-25-022: BRAIN Initiative UH3 Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System
NIH's BRAIN Initiative UH3 opportunity funds first-in-human and early clinical studies of next-generation CNS recording or stimulation devices that are ready for milestone-based advancement toward translation and clinical adoption.